Cargando…
Clinical Trials of Stem Cell Treatment for Spinal Cord Injury
There are more than one million patients worldwide suffering paralysis caused by spinal cord injury (SCI). SCI causes severe socioeconomic problems not only to the patients and their caregivers but also to society; therefore, the development of innovative treatments is crucial. Many pharmacological...
Autores principales: | Yamazaki, Kazuyoshi, Kawabori, Masahito, Seki, Toshitaka, Houkin, Kiyohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313002/ https://www.ncbi.nlm.nih.gov/pubmed/32498423 http://dx.doi.org/10.3390/ijms21113994 |
Ejemplares similares
-
Mesenchymal Stem Cell Sheet Promotes Functional Recovery and Palliates Neuropathic Pain in a Subacute Spinal Cord Injury Model
por: Yamazaki, Kazuyoshi, et al.
Publicado: (2021) -
FTY720 Attenuates Neuropathic Pain after Spinal Cord Injury by Decreasing Systemic and Local Inflammation in a Rat Spinal Cord Compression Model
por: Yamazaki, Kazuyoshi, et al.
Publicado: (2020) -
Intravenous transplantation of amnion-derived mesenchymal stem cells promotes functional recovery and alleviates intestinal dysfunction after spinal cord injury
por: Takamiya, Soichiro, et al.
Publicado: (2022) -
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke
por: Kawabori, Masahito, et al.
Publicado: (2020) -
FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment
por: Wang, Zifeng, et al.
Publicado: (2020)